Zebra Technologies Corporation reported third-quarter net sales of $1,614 million, up 22.3%, and net income of $164 million; operating income rose to $237 million from $183 million.
ZBRA · Zebra Technologies Corp
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Zebra delivered record quarterly sales exceeding $1.6 billion, grew more than 22%, and raised full-year sales growth guidance to approximately 17%, while guiding to fully mitigate an approximately $145 million memory cost headwind.
Zebra Technologies Corporation reported third-quarter net sales of $1,614 million, up 22.3% year-over-year, net income of $164 million and diluted EPS of $3.43. It raised full-year outlook, with fourth-quarter sales growth expected between 10% and 14% and free cash flow of at least $1 billion.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Aug 4, 2026TL;DR. Zebra delivered record Q2 results with sales of $1,557M and non-GAAP EPS of $6.35, and raised its full-year 2026 sales growth outlook to 14–16% (up three points at the midpoint), though guidance reflects an ongoing memory supply/cost headwind of ~$120M and Q3 EBITDA margin steps down to ~22%.
- + Q2 sales grew 20.4% to a record $1,557M with 9.2% organic growth and non-GAAP EPS up 75.9% to $6.35.
- + Raised full-year 2026 sales growth outlook to 14–16% (three-point increase at the midpoint), with adjusted EBITDA margin now 23.5–24.0% and non-GAAP EPS of $20.75–$21.25.
- + Strong broad-based demand across regions and end markets, with healthcare the highest growth vertical and double-digit growth in retail, manufacturing, and healthcare.
- − Q3 guidance implies a margin step-down, with adjusted EBITDA margin of approximately 22% (down from Q2's 27.7%) driven by removal of the $73M IEEPA tariff recovery and a step-up in memory costs.
- − Management stated unconstrained demand would take results to the high end of the outlook range, indicating the midpoint guide is deliberately supply-constrained.
- − EMEA growth lagged other regions at 7% and continued softness in the Middle East was cited due to geopolitical challenges.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA (Non-GAAP) non-GAAP | $778M | Six Months Ended July 4, 2026 | — |
| Adjusted EBITDA margin non-GAAP | 27.7% | the second quarter ended July 4, 2026 | — |
| Adjusted Gross Margin non-GAAP | 53.3% | Three Months Ended July 4, 2026 | — |
| Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in mil | $691M | the three months ended July 4, 2026 filing | — |
| AVA Organic Net sales growth non-GAAP | 11.4% | the three months ended July 4, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP AVA Reported GAAP Net sales growth 13.5%
-2.3% Impact of foreign currency translations
+0.2% Impact of acquisitions and dispositions
= AVA Organic Net sales growth 11.4%
|
|||
| Average Price Paid per Share | $228.68 | the three months ended July 4, 2026 filing | — |
| CF Organic Net sales growth non-GAAP | 7.5% | the three months ended July 4, 2026 filing | — |
| Consolidated Organic Net sales growth non-GAAP | 6.8% | Six Months Ended July 4, 2026 | — |
| Free cash flow non-GAAP | 361M | the first six months of 2026 | — |
| Non-GAAP diluted EPS non-GAAP | $6.35 | the second quarter ended July 4, 2026 | — |
| Non-GAAP Net income non-GAAP | $305M | Three Months Ended July 4, 2026 | — |
| Share repurchases | 268M | the second quarter ended July 4, 2026 | — |
| Shares repurchased | 1,173,993 | the second quarter of 2026 filing | — |
| Total Number of Shares Purchased | 1,173,993 | the three months ended July 4, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Communication Equipment — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ZBRA
this stock
Zebra Technologies Corp
|
$15.26B | +33.4% | +8.3% | 26.1 | 2.8% |
|
CSCO
Cisco Systems, Inc.
|
$377.07B | +24.2% | +2.8% | 28.7 | 1.5% |
|
MSI
Motorola Solutions, Inc.
|
$87.83B | +38.6% | +5.7% | 42.8 | 2.1% |
|
HPE
Hewlett Packard Enterprise Co
|
$64.10B | +101.0% | +13.8% | 24.9 | 3.5% |
|
LITE
Lumentum Holdings Inc.
|
$54.11B | +61.9% | +24.6% | — | 8.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 3, 2026
- This year
- 12
Zebra Technologies Corporation reported third-quarter net sales of $1,614 million, up 22.3% year-over-year, net income of $164 million and diluted EPS of $3.43. It raised full-year outlook, with fourth-quarter sales growth expected between 10% and 14% and free cash flow of at least $1 billion.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ZBRA | +0.6% | -12.2% | +28.4% | -10.3% | +33.4% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -2.0% | -11.0% | +27.9% | -10.1% | +22.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.